OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CDKN2A/B homozygous deletion sensitizes IDH-mutant glioma to CDK4/6 inhibition
Ali M. Nasser, Lisa Melamed, Ethan A. Wetzel, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 14, pp. 2996-3005
Closed Access | Times Cited: 6
Ali M. Nasser, Lisa Melamed, Ethan A. Wetzel, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 14, pp. 2996-3005
Closed Access | Times Cited: 6
Showing 6 citing articles:
A Single-Arm Phase 2 Study of Abemaciclib in Adult Patients with Recurrent Grade 3 Oligodendroglioma
Carson A. Wills, Suyash Mohan, Ali Nabavizadeh, et al.
Neuro-Oncology Advances (2025) Vol. 7, Iss. 1
Open Access
Carson A. Wills, Suyash Mohan, Ali Nabavizadeh, et al.
Neuro-Oncology Advances (2025) Vol. 7, Iss. 1
Open Access
Future Directions in the Treatment of Low-Grade Gliomas
Connor J. Kinslow, Minesh P. Mehta
The Cancer Journal (2025) Vol. 31, Iss. 1
Closed Access
Connor J. Kinslow, Minesh P. Mehta
The Cancer Journal (2025) Vol. 31, Iss. 1
Closed Access
Treatment of Isocitrate Dehydrogenase-Mutant Gliomas
Sofia Chernet, Hannah Kim, Ankush Bhatia, et al.
Advances in Oncology (2025)
Closed Access
Sofia Chernet, Hannah Kim, Ankush Bhatia, et al.
Advances in Oncology (2025)
Closed Access
Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A
Christian Migliarese, Yinon Sadeh, Consuelo Torrini, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Christian Migliarese, Yinon Sadeh, Consuelo Torrini, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade glioma
Kevin C. Johnson, An‐Chi Tien, Jun Jiang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Kevin C. Johnson, An‐Chi Tien, Jun Jiang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design
Ethan A. Wetzel, Amin I. Nohman, Annie L. Hsieh, et al.
Journal of Neuro-Oncology (2024)
Open Access
Ethan A. Wetzel, Amin I. Nohman, Annie L. Hsieh, et al.
Journal of Neuro-Oncology (2024)
Open Access
Identifying Therapeutic Opportunities for Glioma: Mendelian Randomization Analysis of the Druggable Genome
Sheng Zhong, Lin Pan, Wenzhuo Yang, et al.
(2024)
Closed Access
Sheng Zhong, Lin Pan, Wenzhuo Yang, et al.
(2024)
Closed Access
